We are live on
!
Find out more
FBC
Fairfield, Bush & Co Portfolio holdings
AUM
$180M
1-Year Est. Return
39.51%
This Fund
S&P 500
This Quarter
Est. Return
+1.42%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$344M
AUM Growth
-$18.5M
(-5.1%)
Cap. Flow
-$19.1M
Cap. Flow
% of AUM
-5.55%
Top 10 Holdings %
Top 10 Hldgs %
36.45%
Holding
202
New
45
Increased
28
Reduced
87
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$2.05M |
| 2 |
FedEx
FDX
|
+$1.87M |
| 3 |
Union Pacific
UNP
|
+$1.83M |
| 4 |
Apple
AAPL
|
+$1.81M |
| 5 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$988K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$6.94M |
| 2 |
Procter & Gamble
PG
|
+$2.82M |
| 3 |
TSMC
TSM
|
+$1.98M |
| 4 |
Lowe's Companies
LOW
|
+$1.85M |
| 5 |
Microsoft
MSFT
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.01% |
| 2 | Healthcare | 15.95% |
| 3 | Consumer Staples | 13.72% |
| 4 | Financials | 12.49% |
| 5 | Consumer Discretionary | 11.54% |
Similar funds
KCM
AG
AIC
PCA
HIC
V
RVM
FFA
Fairfield, Bush & Co's Q1 2018 Portfolio in Review
As of Q1 2018, Fairfield, Bush & Co held 202 positions worth $344M, down 5.1% from $363M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Fairfield, Bush & Co withdrew a net $19.1M in Q1 2018, closing 8 positions and reducing 87 holdings. Its most notable exit was Juno Therapeutics, Inc., an estimated $826K position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Fairfield, Bush & Co opened a new position in Nike worth $2.06M.
- Fairfield, Bush & Co's largest Q1 2018 buy was Nike: 31,000 shares worth $2.06M.
- Fairfield, Bush & Co added most to FedEx in Q1 2018, an estimated $1.87M increase.
- Fairfield, Bush & Co's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $6.94M.
- Fairfield, Bush & Co fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $826K.
- Fairfield, Bush & Co's ten largest holdings make up 36% of its $344M portfolio in Q1 2018.
- Fairfield, Bush & Co opened 45 new positions and closed 8 in Q1 2018.
- Fairfield, Bush & Co's portfolio value fell 5.1% quarter-over-quarter to $344M.
Based on Fairfield, Bush & Co's 13F filing for Q1 2018, filed 9 May 2018.